Comprehensive Dermatologic Drug Therapy

• Part I: Introduction1 Basic Principles of Pharmacology2 Principles for Maximizing the Safety of Dermatologic Drug Therapy3 Polymorphisms: Why Individual Drug Responses Vary4 Adherence to Drug Therapy5 Medical Decision MakingPart II: Important Drug Regulatory Issues6 The FDA Drug Approval Process7 Pharmacovigilance: Verifying that Drugs Remain Safe8 Drugs Taken Off the Market: Important Lessons LearnedPart III: Systemic Drugs for Infectious Diseases9 Systemic Antibacterial Agents10 Systemic Antifungal Agents11 Systemic Antiviral Agents12 Systemic Antiparasitic AgentsPart IV: Systemic Immunomodulatory Drugs13 Systemic Corticosteroids14 Methotrexate15 Azathioprine16 Mycophenolates17 Cyclosporine18 Phosphodiesterase-4 and Janus Kinase Inhibitors19 Cytotoxic Agents20 Dapsone21 Antimalarial Agents22 Systemic RetinoidsPart V: Drugs Used in Conjunction with UV or Visible Light23 Psoralen Plus Ultraviolet A Photochemotherapy and Other Phototherapy Modalities24 Extracorporeal Photochemotherapy (Photopheresis)25 Photodynamic TherapyPart VI: Biologic Therapeutics26 Tumor Necrosis Factor Inhibitors27 Interleukin 12/23 Inhibitors28 Interleukin 17 Inhibitors29 Interleukin 23 Inhibitors30 Rituximab31 Additional Biologic Therapeutics: Dupilumab, Omalizumab, OthersPart VII: Miscellaneous Systemic Drugs32 Antihistamines33 Vasoactive and Antiplatelet Agents34 Antiandrogens and Androgen Inhibitors35 Psychotropic Agents36 Intravenous Immunoglobulin Therapy37 Systemic Anticancer Agents: Dermatologic Indications and Adverse Events38 Hedgehog Pathway Inhibitors39 Drugs for the Skinternist40 Miscellaneous Systemic DrugsPart VIII: Topical Drugs for Infectious Diseases41 Topical Antibacterial Agents42 Topical Antifungal Agents43 Topical and Intralesional Antiviral Agents44 Topical Antiparasitic AgentsPart IX: Topical Immunomodulatory Drugs45 Topical Corticosteroids46 Topical Retinoids47 Topical and Intralesional Chemotherapeutic Agents48 Topical Calcineurin Inhibitors49 Topical Vitamin D3Part X: Miscellaneous Topical Drugs50 Sunscreens51 Therapeutic Shampoos52 ?-Hydroxy Acids53 Chemical Peels54 Products for the Care of Chronic Wounds55 Agents Used for Treatment of Hyperkeratosis56 Irritants and Allergens: When to Suspect Topical Therapeutic Agents57 Miscellaneous Topical AgentsPart XI: Injectable and Mucosal Routes of Drug Administration58 Local Anesthetics59 Injectable Dermal and Subcutaneous Fillers60 Botulinum Toxin Injections61 Oral Mucosal TherapeuticsPart XII: Major Adverse Effects From Systemic Drugs62 Hepatotoxicity of Dermatologic Drug Therapy63 Hematologic Toxicity of Drug Therapy64 Drug-induced Malignancy65 Dermatologic Drugs During Pregnancy and Lactation66 Drug Interactions67 Cutaneous Drug Reactions With Systemic FeaturesPart XIII: Special Pharmacology and Therapeutics Topics68 Informed Consent and Risk Management69 Compounding in Dermatology70 Dermatologic Drug Therapy in ChildrenAppendix I Core Questions for Understanding Systemic Dermatologic DrugsAppendix II The Most Potentially Serious Drug Interactions

Doody's Core Titles® 2022"I highly recommend this book. Having this reference in the medical library will make it a snap for dermatologists to be at the top of their game."-Patricia Wong, MD (Private Practice) Doody's Review Service: 94-4 Stars!